Suven Pharmaceuticals Ltd (SUVENPHAR.NS) Financials

SUVENPHAR.NS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 ? ?
2023-09-30 21.2 billion 1.8 billion
2023-06-30 ? ?
2023-03-31 19.7 billion 2.3 billion

SUVENPHAR.NS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 255.0 million ?
2023-09-30 237.8 million ?
2023-06-30 250.8 million ?
2023-03-31 239.2 million ?

SUVENPHAR.NS Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 467.5 million
2023-09-30 795.6 million
2023-06-30 1.2 billion
2023-03-31 1.2 billion

SUVENPHAR.NS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - -
2023-09-30 7.1 billion - 16.5 million
2023-06-30 4.9 billion - -
2023-03-31 4.9 billion - 11.8 million

SUVENPHAR.NS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 254.1 million
2023-09-30 254.2 million
2023-06-30 254.4 million
2023-03-31 254.6 million

SUVENPHAR.NS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 22.8 million - -
2023-09-30 - 44.7 million - -
2023-06-30 - 20.9 million - -
2023-03-31 - 20.1 million - -

SUVENPHAR.NS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2.2 billion 1.1 billion
2023-09-30 2.3 billion 868.8 million
2023-06-30 3.5 billion 1.3 billion
2023-03-31 3.7 billion 1.6 billion

SUVENPHAR.NS

Price: ₹644.15

52 week price:
469.45
768.00

Earnings Per Share: 14.56 INR

P/E Ratio: 39.24

Exchange: NSI

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 165.2 billion

Average Dividend Frequency: 3

Links: